Xcout IntelSign inSubscribe

Hikma Ventures

United Kingdom

Hikma Ventures is the corporate venture capital arm of Hikma Pharmaceuticals. It invests in innovative healthcare companies, particularly businesses developing medicines, healthcare technologies, and services relevant to Hikma’s pharmaceutical markets.

Subscribe to see Hikma Ventures’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

Hikma Ventures at a glance

Hikma Ventures is a company headquartered in United Kingdom. Xcout tracks 8 named people at Hikma Ventures, including Lana Ghanem (Managing Director).

Headquarters
United Kingdom

Hikma Ventures leadership

  • Lana GhanemManaging Director
  • Mazen DarwazahExecutive Vice Chairman, President of MENA
  • Bassam KanaanEVP, Corporate Development and M&A
  • Haya KhouryAnalyst
  • Salma Al-Zu biPrincipal
  • Ali Al-HusryNon-Executive Director

2 more named people on record for Hikma Ventures, with roles, board committees and tenure — see the full roster →

Hikma Ventures competitors

A few of Hikma Ventures's closest competitors — see the full list of competitors and alternatives →

HIKMA PHARMACEUTICALS PLCHIK · PharmaceuticalsLondon, United Kingdom
74% matchPublic

Hikma Pharmaceuticals PLC is a global pharmaceutical enterprise involved in the creation, production, promotion, and distribution of a wide array of generic, branded, and licensed medicinal solutions. These offerings are presented in various dosage formats, including solid, semi-solid, liquid, and injectable forms. The company's operations are strategically structured into three core segments: Injectables, Generics, and Branded. The Injectables division specializes in providing generic injectable medications, predominantly for hospital environments. Conversely, the Generics segment is responsible for supplying oral and other non-injectable generic pharmaceuticals to the consumer retail market. The Branded unit caters to both retail and hospital clients with its proprietary generic and in-licensed products. Hikma's comprehensive product portfolio addresses a broad spectrum of medical conditions, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, and respiratory ailments. The firm boasts a substantial international presence, conducting business across the United Kingdom, the United States, the Middle East, North Africa, and various European countries. Founded in 1978, the company's corporate headquarters are situated in London, United Kingdom.

Market cap$4.6B
Employees9,400
HIKMA PHARMACEUTICALS PLC competitors & alternatives →

Get Hikma Ventures's news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Something wrong or missing about Hikma Ventures? Suggest a correction

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

Hikma Ventures — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on Hikma Ventures in Xcout Intel

  • 8 named people with titles, LinkedIn and board committees
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →